Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

PURPOSE: Outcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure. We examined the additional prognostic value of circulating tumor DNA (ctDNA) before and during therapy for predicting patient outcomes. PAT...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Kurtz, David M., Scherer, Florian, Jin, Michael C., Soo, Joanne, Craig, Alexander F.M., Esfahani, Mohammad Shahrokh, Chabon, Jacob J., Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael S., Advani, Ranjana H., Levy, Ronald, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Meignan, Michel, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2018
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161832/
https://ncbi.nlm.nih.gov/pubmed/30125215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.78.5246
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items